Quick Answer
Jade Biosciences, Inc. reported Stockholders Equity of $332.52 million for fiscal year 2025.
Jade Biosciences, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $332.52M | +810.5% |
| 2024 | -$46.80M | -4680000.0% |
| 2024 | $1.0K | -100.0% |
| 2023 | $109.46M | -13.6% |
| 2022 | $126.74M | -26.5% |
| 2021 | $172.42M | +1392.1% |
| 2020 | -$13.34M | -266.3% |
| 2019 | -$3.64M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $179.35M | +1163.5% | -11.0% |
| June 30, 2025 | $201.56M | +34320.0% | +341.4% |
| March 31, 2025 | -$83.51M | -191.9% | -78.4% |
| December 31, 2024 | -$46.80M | -142.8% | -177.5% |
| September 30, 2024 | -$16.86M | -113.4% | -2763.0% |
| June 30, 2024 | -$589.0K | -100.4% | -100.6% |
| March 31, 2024 | $90.90M | -19.6% | -16.9% |
| December 31, 2023 | $109.46M | -13.6% | -12.9% |
- Jade Biosciences, Inc. showed an increase of +810.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, Jade Biosciences, Inc.’s stockholders equity has grown by 9227.6% (from -$3.64 million to $332.52 million).
- The most recent figure is from Jade Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: